Ipsen acquires Memo Therapeutics, a portfolio company of Ysios Capital

by Ysios Capital

Under the terms of the agreements, shareholders of Memo Therapeutics AG will receive a 200 million EUR payment on a cash-free and debt-free basis at closing of the transaction, and deferred payments c...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Marsh Acquires the Remaining Stake in As...

by Marsh

Founded in 2020, Asterra has established a strong presence in the Span...

Photos Stream